01 1Taro Pharmaceutical Industries
01 1PROGUANIL HYDROCHLORIDE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-23
Pay. Date : 2014-02-28
DMF Number : 26103
Submission : 2012-11-28
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PROGUANIL HYDROCHLORIDE USP, with a corresponding US DMF Number 26103.
Remarkably, this DMF maintains an Active status since its submission on November 28, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 23, 2015, and payment made on February 28, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
